Skoči na glavni sadržaj

Cardiologia Croatica, Vol. 16 No. 9-10, 2021.

Sažetak sa skupa

https://doi.org/10.15836/ccar2021.295

Vascular closure during transcatheter aortic valve implantation: Literature review and experience from University Hospital Centre Split

Ivica Kristić orcid id orcid.org/0000-0002-9882-9145 ; University Hospital Centre Split
Andrija Matetić orcid id orcid.org/0000-0001-9272-6906 ; University Hospital Centre Split
Frane Runjić orcid id orcid.org/0000-0001-6639-5971 ; University Hospital Centre Split
Nikola Crnčević orcid id orcid.org/0000-0002-1399-3406 ; University Hospital Centre Split
Jakša Zanchi orcid id orcid.org/0000-0003-2700-2121 ; University Hospital Centre Split
Matjaž Bunc orcid id orcid.org/0000-0001-7269-8944 ; University Medical Centre Ljubljana

Puni tekst: engleski pdf 533 Kb

str. 295-296

preuzimanja: 239

citiraj

Preuzmi JATS datoteku

Sažetak

Ključne riječi

vascular closure device; transcatheter aortic valve implantation; vascular access

Hrčak ID:

261733

URI

https://hrcak.srce.hr/261733

Datum izdavanja:

1.9.2021.

Posjeta: 767 *

Copyright: 2021, Croatian Cardiac Society

Date received: 30 July 2021

Date accepted: 05 August 2021

Publication date (print and electronic): September 2021

Volume: 16

Issue: 9-10

Pages: 295-296

Publisher ID: CC 2021 16_9-10_295-6

DOI: 10.15836/ccar2021.295

Article Information (continued)

Categories:

Subject: Aortic valve / treatment challenges

Categories:

Subject: Extended Abstract

KEYWORDS: :

KEYWORDS:

Keyword: vascular closure device

Keyword: transcatheter aortic valve implantation

Keyword: vascular access

Vascular closure during transcatheter aortic valve implantation: Literature review and experience from University Hospital Centre Split

[https://orcid.org/0000-0002-9882-9145] Ivica Kristić[1]

[https://orcid.org/0000-0001-9272-6906] Andrija Matetić[1][*]

[https://orcid.org/0000-0001-6639-5971] Frane Runjić[1]

[https://orcid.org/0000-0002-1399-3406] Nikola Crnčević[1]

[https://orcid.org/0000-0003-2700-2121] Jakša Zanchi[1]

[https://orcid.org/0000-0001-7269-8944] Matjaž Bunc[2]

 

[1] University Hospital Centre Split, Split, Croatia

[2] University Medical Centre Ljubljana, Ljubljana, Slovenia

Author notes:

Correspondence to: [*] ADDRESS FOR CORRESPONDENCE: Andrija Matetić, Klinički bolnički centar Split, Spinčićeva 1, 
HR-21000 Split, Croatia. / Phone: +385-98-954-6455 / E-mail: andrija.matetic@gmail.com

Background and Aims: Vascular closure devices (VCDs) have emerged as a routine method for vascular management. Their evolution allowed for further progress and development of interventional cardiology irrespective of the increased frailty of the treated population (1). This short review aims to present available VCDs and describe the most utilized regimes in everyday practice. In addition, we aimed to present a VCDs protocol at the University Hospital Centre Split.

Materials and Methods: A literature search in the PubMed database was conducted yielding a total of 2,380 research articles in the period of 1975 to 2021. Out of these, 246 articles were review articles. A significant positive trend in the number of published articles was observed across the years (Figure 1).

Figure 1 Overview of the indexed publications focused on vascular closure devices over the years.
CC202116_9-10_295-6-f1

Results: Different types of VCDs exist according to the closure mechanism. Suture-based VCDs include Abbott Perclose ProGlide and Abbott Prostar XL. Plug-based VCDs encompass Terumo Angio-Seal, Terumo FemoSeal, Cordis MynxGrip, Teleflex Manta, Vivasure Medical PerQSeal, and InSeal Medical InSeal (2). The mechanism of vascular closure by both suture- and plug-based VCDs is presented inFigure 2. Large bore access often requires a combination of the different types of VCDs, and their utilization is literally limitless, depending on the center preferences. Among different options, the most utilized vascular closure method at the University Hospital Centre Split during transcatheter aortic valve replacement (TAVR) combines Abbott Perclose ProGlide and Terumo Angio-Seal allowing for adequate closure and vascular management (3). After the TAVR finalization, the percutaneous sutures are tightened around an 8 French sheath, followed by the insertion of the Terumo Angio-Seal device according to standards.

Figure 2 Overview and mechanism of action of different vascular closure devices.
CC202116_9-10_295-6-f2

Conclusions: In conclusion, VCDs represent a modern ubiquitary method for vascular access management, enabling safer and comfortable procedures in a wider patient population. Research on VCDs has substantially increased in recent years. Utilized regimes depend on the access size and center preferences.

LITERATURE

1 

Dauerman HL. Rewriting the history of vascular closure devices. EuroIntervention. 2014 June;10(2):175–7. https://doi.org/10.4244/EIJV10I2A29 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/24952054

2 

Noori VJ, Eldrup-Jørgensen J. A systematic review of vascular closure devices for femoral artery puncture sites. J Vasc Surg. 2018 September;68(3):887–99. https://doi.org/10.1016/j.jvs.2018.05.019 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/30146036

3 

Ko TY, Kao HL, Liu YJ, Yeh CF, Huang CC, Chen YH, et al. Intentional combination of ProGlide and Angio-Seal for femoral access haemostasis in transcatheter aortic valve replacement. Int J Cardiol. 2019 October 15;293:76–9. https://doi.org/10.1016/j.ijcard.2019.05.055 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/31155328

This display is generated from NISO JATS XML with jats-html.xsl. The XSLT engine is libxslt.